Enhertu contains fam-trastuzumab deruxtecan-nxki, which is typically a HER2-directed antibody and topoisomerase inhibitor conjugate. This medicinal product (fam-trastuzumab deruxtecan-nxki) is an antibody-drug conjugate composed of (3) three different components: a humanized anti-HER2 IgG1 monoclonal antibody, covalently associated with, a topoisomerase inhibitor, via tetrapeptide-based cleavable linker. The medicine Enhertu injection is approved by the FDA for the treatment of several types of cancer:
- HER2+ Metastatic Breast Cancer
- HER2-Low Metastatic Breast Cancer
- HER2+ Advanced Stomach Cancer
- HER2-Mutant Metastatic Lung cancer
Note: Those who were diagnosed with HR+ HER2- or TNBC metastatic breast cancer, may actually have low levels of HER2.
Enhertu is supplied for injection of 100 mg lyophilized powder in a single-dose vial and intended to be used as an intravenous (IV) line by a health specialist. It is given a single time every three weeks (21-day treatment cycle). Pre-medications should be given prior to infusion to prevent nausea and vomiting. In case of infusion-related, the infusion should be stopped temporarily.
How and Where to Buy Enhertu:
You can order/buy enhertu 100 mg injection online from Indian Pharma Network, if the drug Enhertu- fam-trastuzumab deruxtecan-nxki is not available or approved in your native country. IPN helps Patients, Doctors, and Hospitals as a facilitator to import Enhertu (fam-trastuzumab deruxtecan-nxki) on a valid prescription under Name Patient Supply. In some countries, we might also need an import license.
For abroad patients, Enhertu can be made available once they send an inquiry to find this medication in Australia, New Zealand, China, Uganda, Jordan, Mauritius, Saudi Arabia, Algeria, Mexico, Philippines, Mongolia, Argentina, Indonesia, Uzbekistan, Brazil, Cambodia, Turkmenistan, Chile, Singapore, Poland, Moldova, Thailand, Ukraine, Hong Kong, Turkey, Vietnam, Latvia, UAE, Georgia, Peru, Iran, Slovakia, Switzerland, Kazakhstan, Zimbabwe, Iraq, Italy, Romania, Pakistan, Bangladesh, Sri Lanka and other countries across the world.
Indian Pharma Network is a WHO GDP & ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer of Enhertu from India. Enhertu is also known as fam-trastuzumab deruxtecan-nxki and Manufactured by AstraZeneca and Daiichi Sankyo Company, Limited. It is available in a strength of 20 mg/mL injection for intravenous use. Enhertu – 20 mg/mL fam-trastuzumab deruxtecan-nxki is supplied for Tenders/ Imports/ Name patient supply/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.
